Assessing COVID-19 Booster Hesitancy and Its Correlates: An Early Evidence from India

The emergence of SARS-CoV-2 mutants, waning immunity, and breakthrough infections prompted the use of booster doses of the COVID-19 vaccine to fight against the pandemic. India started booster doses in January 2022 and it is critical to determine the intention of booster dose uptake and its correlat...

Descripción completa

Detalles Bibliográficos
Autores principales: Achrekar, Geetanjali C., Batra, Kavita, Urankar, Yashashri, Batra, Ravi, Iqbal, Naved, Choudhury, Sabiha A., Hooda, Deepti, Khan, Roohi, Arora, Suraj, Singh, Aditi, Chirico, Francesco, Sharma, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323084/
https://www.ncbi.nlm.nih.gov/pubmed/35891212
http://dx.doi.org/10.3390/vaccines10071048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323084/
https://www.ncbi.nlm.nih.gov/pubmed/35891212
http://dx.doi.org/10.3390/vaccines10071048

Ejemplares similares